World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
15030
World Ranking
3491
National Ranking
1621

Otto O. Yang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Otto O. Yang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 256 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Otto O. Yang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Otto O. Yang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Otto O. Yang is affiliated with the University of California, Los Angeles in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on several subfields including Infectious Diseases, Immunology, Neurology, Epidemiology, and Molecular Biology.

The main topics in their work include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, Immune Cell Function and Interaction, HIV Research and Treatment, SARS-CoV-2 detection and testing, and CAR-T cell therapy research.

Otto O. Yang has authored several recent papers notable for their contributions to understanding COVID-19 and immune responses. These include:

  • Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19 (2020), published in New England Journal of Medicine
  • Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial (2022), published in The Lancet Respiratory Medicine
  • Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses (2021), published in ACS Nano
  • Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia (2023), published in JAMA
  • The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2 (2021), published in Cell Reports Medicine

Their frequent coauthors include:

  • F. Javier Ibarrondo
  • Jennifer A. Fulcher
  • Grace M. Aldrovandi
  • Nicole H. Tobin
  • Kathie G. Ferbas

Otto O. Yang's research has been published predominantly in the following venues:

  • Clinical Infectious Diseases
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • New England Journal of Medicine

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

    F. Javier Ibarrondo;Jennifer A. Fulcher;David Goodman-Meza;Julie Elliott

  • Hydrodynamic stretching of single cells for large population mechanical phenotyping

    Daniel R. Gossett;Henry T. K. Tse;Serena A. Lee;Yong Ying

  • Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1

    Alexander M. Cole;Teresa Hong;Lee Ming Boo;Tung Nguyen

  • Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.

    Ludwig Wagner;Otto O. Yang;Eduardo A. Garcia-Zepeda;Yimin Ge

  • Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

    O O Yang;S A Kalams;A Trocha;H Cao

  • Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.

    Jonah B. Sacha;Chungwon Chung;Eva G. Rakasz;Sean P. Spencer

  • Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.

    Theodoros Kelesidis;Otto Yang

  • Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

    O O Yang;S A Kalams;M Rosenzweig;A Trocha

  • Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

    Fabio Candotti;Kit L. Shaw;Linda Muul;Denise Carbonaro

  • Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection

    Theodoros Kelesidis;Michelle A. Kendall;Otto O. Yang;Howard N. Hodis

  • Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes

    Steven Russell Fauce;Beth D. Jamieson;Allison C. Chin;Ronald T. Mitsuyasu

  • The θ-Defensin, Retrocyclin, Inhibits HIV-1 Entry

    Carsten Münk;Ge Wei;Otto O. Yang;Alan J. Waring

  • Definition of the viral targets of protective HIV-1-specific T cell responses.

    Beatriz Mothe;Anuska Llano;F. Javier Ibarrondo;Marcus Daniels

  • A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model

    Saki Shimizu;Patrick Hong;Balamurugan Arumugam;Lauren Pokomo

  • Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells

    O O Yang;A C Tran;S A Kalams;R P Johnson

  • Determinants of HIV-1 Mutational Escape From Cytotoxic T Lymphocytes

    Otto O. Yang;Phuong Thi Nguyen Sarkis;Ayub Ali;Jason D. Harlow

  • Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes

    Otto O. Yang;Phuong Thi Nguyen;Spyros A. Kalams;Tanya Dorfman

  • HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells.

    Anjie Zhen;Masakazu Kamata;Valerie Rezek;Jonathan Rick

  • Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir

    Todd T. Brown;Carlee Moser;Judith S. Currier;Heather J. Ribaudo

  • CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.

    Otto O. Yang;Bruce D. Walker

Frequent Co-Authors

Beth D. Jamieson
Beth D. Jamieson University of California, Los Angeles
Judith S. Currier
Judith S. Currier University of California, Los Angeles
Bruce D. Walker
Bruce D. Walker Harvard University
Peter A. Anton
Peter A. Anton University of California, Los Angeles
Irvin S. Y. Chen
Irvin S. Y. Chen University of California, Los Angeles
Spyros A. Kalams
Spyros A. Kalams Vanderbilt University Medical Center
Jerome A. Zack
Jerome A. Zack University of California, Los Angeles
Grace A. McComsey
Grace A. McComsey Case Western Reserve University
Alicja Trocha
Alicja Trocha Ragon Institute of MGH, MIT and Harvard
Eric S. Daar
Eric S. Daar Lundquist Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can broaden career opportunities. Psychiatric Nurse Practitioner roles, for example, blend specialized medical knowledge with mental health expertise. Prospective students can find programs with excellent clinical training by reviewing the top pmhnp programs, which emphasize hands-on experience essential for success.

Cost is another crucial consideration. Many students seek flexible options without financial strain, making the cheapest online pmhnp certificate programs a valuable resource. These programs help reduce debt while maintaining quality education standards.

Salary expectations also influence educational pathways. Understanding how much do dnp nurses make across different states can guide candidates in selecting locations and specializations that offer strong financial rewards alongside fulfilling work.

For nurses aiming to advance their careers, transitioning between specialties is common. Information on acnp programs provides insight into the steps necessary to move from Family Nurse Practitioner roles to Acute Care Nurse Practitioner positions, expanding clinical scope and expertise.

Best Scientists Citing Otto O. Yang

Trending Scientists

Recently Published Articles